VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 134 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $765 | -64.8% | 58,847 | -52.6% | 0.00% | -100.0% |
| Q1 2024 | $2,173 | -54.6% | 124,148 | -43.5% | 0.00% | -50.0% |
| Q4 2023 | $4,783 | +137.0% | 219,593 | +66.9% | 0.00% | +100.0% |
| Q3 2023 | $2,018 | -67.1% | 131,557 | -48.9% | 0.00% | -75.0% |
| Q2 2023 | $6,126 | +107.4% | 257,536 | +121.7% | 0.00% | +300.0% |
| Q1 2023 | $2,954 | +1.8% | 116,143 | +16.9% | 0.00% | 0.0% |
| Q4 2022 | $2,901 | -100.0% | 99,320 | -84.8% | 0.00% | -93.3% |
| Q3 2022 | $13,409,000 | +6225.0% | 653,751 | +3473.4% | 0.02% | – |
| Q2 2022 | $212,000 | -32.5% | 18,295 | +7.6% | 0.00% | – |
| Q1 2022 | $314,000 | – | 17,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,882,671 | $50,513,550 | 3.22% |
| Rosalind Advisors, Inc. | 300,000 | $3,903,000 | 3.00% |
| Fairmount Funds Management LLC | 1,845,813 | $24,014,027 | 2.71% |
| Ghost Tree Capital, LLC | 587,708 | $7,646,081 | 2.39% |
| COMMODORE CAPITAL LP | 2,528,032 | $32,889,696 | 2.24% |
| ACUTA CAPITAL PARTNERS, LLC | 199,433 | $2,594,623 | 2.18% |
| 5AM Venture Management, LLC | 736,595 | $9,583,101 | 2.14% |
| Vivo Capital, LLC | 1,678,207 | $21,833,473 | 2.02% |
| TANG CAPITAL MANAGEMENT LLC | 1,392,925 | $18,121,954 | 1.85% |
| Kynam Capital Management, LP | 1,750,000 | $22,767,500 | 1.76% |